NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-087-2004-0-ES-10 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME ES EP 04712898.8 Expired
NCI E-087-2004-0-GB-12 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME GB EP 04712898.8 Expired
NCI E-087-2004-0-EP-09 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME EP National Stage 04712898.8 Expired
NCI E-087-2004-0-IT-13 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAFINGOL AND METHODS OF USING THE SAME IT EP 04712898.8 Expired
NCI E-265-1994-1-US-04 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE, INT6, US DIV 10/783,415 7067635 Abandoned PDF
NCI E-087-2004-0-PCT-02 Novel And Stable Pharmaceutical Formulations Of L-threo-dihydrosphingosine ("Safingol") PCT PCT PCT/US2004/004960 Expired
NCI E-200-1998-0-AU-09 Fitness Assay and Associated Methods AU DIV 2004200629 Expired
NCI E-003-2003-0-PCT-02 Amplification or Overexpression of MLL Septin-Like Fusion (MSF) and Septin9 and Methods Related Thereto PCT PCT PCT/US2004/04468 Expired
NCI E-325-2002-0-US-01 Antibodies That Bind POTE and Uses Thereof US 60/546,058 Abandoned
NICHD E-113-2002-0-CA-05 Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates. CA National Stage 2516319 Abandoned
NICHD E-113-2002-0-AU-04 Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates AU National Stage 2004217988 Abandoned
NICHD E-020-2004-0-US-02 In Vitro Test To Detect Risk Of Preeclampsia US ORD 10/779,360 7541182 Expired PDF
CC E-351-2003-0-US-01 Determination of Feature Boundaries in a Digital Representation of an Anatomical Structure US ORD 10/779,210 7454045 Issued PDF
NIAAA E-321-2001-0-US-03 Novel Vasoconstrictor Cannabinoid Analogs US National Stage 10/486,810 7109245 Expired PDF
NICHD E-113-2002-0-PCT-02 An Alternate Route To 17a-acetoxy-11B-(4-N,N-dimethylamino-phenyl)-19- norpregna-4,9-diene-3, 20-dione (CDB-2914) PCT PCT PCT/US2004/04246 Abandoned
NEI E-008-2004-0-EP-05 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y EP National Stage 04710659.6 Abandoned
NEI E-008-2004-0-IT-12 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y IT EP 04710659.6 Abandoned
NEI E-008-2004-0-FR-10 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y FR EP 04710659.6 Abandoned
NEI E-008-2004-0-DE-08 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y DE EP 04710659.6 Abandoned
NEI E-008-2004-0-LI-13 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y LI EP 04710659.6 Abandoned
NEI E-008-2004-0-CH-07 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y CH EP 04710659.6 Abandoned
NEI E-008-2004-0-GB-11 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y GB EP 04710659.6 Abandoned
NEI E-008-2004-0-ES-09 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y ES EP 04710659.6 Abandoned
NEI E-008-2004-0-CA-04 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y CA National Stage 2555792 Abandoned
NEI E-008-2004-0-AU-03 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y AU National Stage 2004317159 Abandoned
NEI E-008-2004-0-PCT-01 Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y PCT PCT PCT/US2004/04142 Expired
NCI E-231-2002-0-PCT-02 Deazaflavin Compounds and Methods of Use Thereof PCT PCT PCT/US2004/04130 Expired
NICHD E-113-2002-0-EP-06 Method For Preparing 17 A-Acetoxy-11b-(4-N,N-Dimethylaminophenyl)-19-Norpregna-4,9-Diene-3,20-Dione, Intermediates Thereof, And Methods For The Preparation Of Such Intermediates EP National Stage 04711161.2 Abandoned
NCI E-231-2002-0-EP-06 Deazaflavin Compounds and Methods of Use Thereof EP National Stage 04710663.8 Abandoned
NCI E-231-2002-0-CA-04 Deazaflavin Compounds and /Methods of Use Thereof CA National Stage 2514374 Abandoned
NCI E-231-2002-0-HK-07 Deazaflavin Compounds and Methods of Use Thereof HK National Stage 06110323.1 Abandoned
NCI E-231-2002-0-AU-03 Deazaflavin Compounds and Methods of Use Thereof AU National Stage 2004212928 Abandoned
NIEHS E-237-1994-1-JP-31 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE JP DIV 2004-035158 Expired
NCI E-073-2004-0-US-01 Reduction of HIV-1 Replication by a Mutant Apolipoprotein B MRNA Editing Enzyme-Catalytic Polypeptide-Like 3 G (APOBEC3G) US 60/543,941 Abandoned
NHLBI E-071-2004-0-US-01 RF Cycling For Suppressing The Conjugate Signal In Stimulated Echo Nuclear Magnetic Resonance Imaging US 60/544,265 Abandoned
NIDDK E-249-1999-1-US-06 High-Volume On-Line Spectroscopic Composition Testing of Manufactured Pharmaceutical Dosage Units US DIV 10/776,029 7399968 Abandoned PDF
NIDDK E-236-2002-0-PCT-02 Novel Peptide Inhibitor of HIV Fusion that Disrupts the Internal Trimeric Coiled-Coil of GP41 PCT PCT PCT/US2004/03794 Expired
NIEHS E-129-2004-0-US-04 Thermostable UvrA, UvrB, and UvrC Polypeptides And Methods Of Use US National Stage 10/486,480 Abandoned
NIDDK E-236-2002-0-EP-08 Novel Peptide Inhibitor of HIV Fusion that Disrupts the Internal Trimeric Coiled-Coil of GP41 EP National Stage 04709842.1 Abandoned
NIDDK E-236-2002-0-IN-06 Novel Peptide Inhibitor of HIV Fusion that Disrupts the Internal Trimeric Coiled-Coil of GP41 IN National Stage 3427/DELNP/2005 Abandoned
CC E-061-2003-0-US-01 Long Term Retrieveable Venous Filter US 60/543,766 Abandoned
NIAID E-059-2004-0-US-01 Multimeric Protein Toxins To Target Cells Having Multiple Identifying Characteristics US 60/543,417 Abandoned
NIMH E-088-1998-0-AU-08 Strains of Bacteriophage Useful for Rescuing Patients Infected With Vancomycin-Resistant Enterococcus Faecium AU DIV 2004200450 Abandoned
NIA E-141-2000-0-US-03 AGENTS USEFUL FOR REDUCING AMYLOID PRECURSOR PROTEIN AND TREATING DEMANTIA AND METHODS OF USE THEREOF US National Stage 10/415,765 7153882 Expired PDF
NIAID E-194-1999-0-US-04 Production Of Attenuated Respiratory Syncytial Virus Vaccines Involving Modification of M2 ORF2 US CON 10/774,341 Abandoned
NCI E-009-1998-2-US-03 cDNA ENCODING A GENE BOG (B5t OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT US DIV 10/772,988 7342099 Abandoned PDF
NHLBI E-061-2004-0-US-01 Mucus Shaving Apparatus for Endotracheal Tubes US ORD 10/773,570 7051737 Expired PDF
NCI E-010-2004-0-US-01 Activation Of T Cell P38 By Src Kinase-Mediated Tyrosine Phosphorlation: Negative Regulation By The Autoimmune Suppressor Gadd45a US 60/541,993 Abandoned
NIA E-049-2001-0-FR-12 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF FR EP 02748271.0 Expired
NIA E-049-2001-0-DE-11 GLP-1, EXENDIN-4, PEPTIDE ANALOGS AND USES THEREOF DE EP 02748271.0 Expired